EligibleTrials

BurdEn of NEw Onset Atrial FIbrillation in patienTs With Acute Myocardial Infarction

Recruiting · NCT04528511 · Observational (researchers observe without assigning treatment) · Lead sponsor: Shanghai 10th People's Hospital

View the official record on ClinicalTrials.gov →
Atrial fibrillation

Interventions studied

Continuous Electronic Monitor

What this trial is about

To validate the prognostic importance of the burden of new-onset atrial fibrillation (NOAF) complicating acute myocardial infarction (AMI) in a prospectively designed hospital-based registry. To characterize those factors that contribute to the progression of post-MI NOAF burden. To establish a prediction model for the risk stratification of patients with NOAF complicating AMI. To explore the clinical usefulness of NOAF burden in guiding the anticoagulation therapy among patients with post-MI NOAF.

Who can take part

Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)

Inclusion criteria

Exclusion criteria

Where it is running

5 locations listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.